NM_002880.4:c.321-14dupT

Variant summary

Our verdict is Benign. The variant received -16 ACMG points: 0P and 16B. BP6_Very_StrongBA1

The NM_002880.4(RAF1):​c.321-14dupT variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00289 in 1,550,984 control chromosomes in the GnomAD database, including 112 homozygotes. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0039 ( 16 hom., cov: 32)
Exomes 𝑓: 0.0028 ( 96 hom. )

Consequence

RAF1
NM_002880.4 intron

Scores

Not classified

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:8

Conservation

PhyloP100: -0.987

Publications

3 publications found
Variant links:
Genes affected
RAF1 (HGNC:9829): (Raf-1 proto-oncogene, serine/threonine kinase) This gene is the cellular homolog of viral raf gene (v-raf). The encoded protein is a MAP kinase kinase kinase (MAP3K), which functions downstream of the Ras family of membrane associated GTPases to which it binds directly. Once activated, the cellular RAF1 protein can phosphorylate to activate the dual specificity protein kinases MEK1 and MEK2, which in turn phosphorylate to activate the serine/threonine specific protein kinases, ERK1 and ERK2. Activated ERKs are pleiotropic effectors of cell physiology and play an important role in the control of gene expression involved in the cell division cycle, apoptosis, cell differentiation and cell migration. Mutations in this gene are associated with Noonan syndrome 5 and LEOPARD syndrome 2. [provided by RefSeq, Jul 2008]
RAF1 Gene-Disease associations (from GenCC):
  • Noonan syndrome
    Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, ClinGen
  • Noonan syndrome 5
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Genomics England PanelApp, Labcorp Genetics (formerly Invitae), Ambry Genetics, PanelApp Australia, G2P
  • dilated cardiomyopathy 1NN
    Inheritance: AD Classification: STRONG, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics
  • LEOPARD syndrome 2
    Inheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp, Labcorp Genetics (formerly Invitae)
  • familial isolated dilated cardiomyopathy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • Noonan syndrome with multiple lentigines
    Inheritance: AD Classification: SUPPORTIVE, LIMITED Submitted by: Orphanet, ClinGen
  • cardiofaciocutaneous syndrome
    Inheritance: AD Classification: NO_KNOWN Submitted by: ClinGen
  • Costello syndrome
    Inheritance: AD Classification: NO_KNOWN Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -16 ACMG points.

BP6
Variant 3-12609348-T-TA is Benign according to our data. Variant chr3-12609348-T-TA is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 44625.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.0652 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_002880.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
RAF1
NM_002880.4
MANE Select
c.321-14dupT
intron
N/ANP_002871.1
RAF1
NM_001354689.3
c.321-14dupT
intron
N/ANP_001341618.1
RAF1
NM_001354690.3
c.321-14dupT
intron
N/ANP_001341619.1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
RAF1
ENST00000251849.9
TSL:1 MANE Select
c.321-14_321-13insT
intron
N/AENSP00000251849.4
RAF1
ENST00000442415.7
TSL:5
c.321-14_321-13insT
intron
N/AENSP00000401888.2
RAF1
ENST00000900382.1
c.321-14_321-13insT
intron
N/AENSP00000570441.1

Frequencies

GnomAD3 genomes
AF:
0.00391
AC:
594
AN:
151892
Hom.:
16
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000435
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00931
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.0715
Gnomad SAS
AF:
0.00622
Gnomad FIN
AF:
0.000760
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000235
Gnomad OTH
AF:
0.00432
GnomAD2 exomes
AF:
0.00939
AC:
2350
AN:
250296
AF XY:
0.00798
show subpopulations
Gnomad AFR exome
AF:
0.000559
Gnomad AMR exome
AF:
0.0266
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.0689
Gnomad FIN exome
AF:
0.000887
Gnomad NFE exome
AF:
0.000203
Gnomad OTH exome
AF:
0.00656
GnomAD4 exome
AF:
0.00278
AC:
3888
AN:
1398974
Hom.:
96
Cov.:
25
AF XY:
0.00260
AC XY:
1818
AN XY:
699424
show subpopulations
African (AFR)
AF:
0.000435
AC:
14
AN:
32168
American (AMR)
AF:
0.0243
AC:
1085
AN:
44578
Ashkenazi Jewish (ASJ)
AF:
0.0000388
AC:
1
AN:
25798
East Asian (EAS)
AF:
0.0513
AC:
2020
AN:
39338
South Asian (SAS)
AF:
0.00266
AC:
226
AN:
84892
European-Finnish (FIN)
AF:
0.00101
AC:
54
AN:
53266
Middle Eastern (MID)
AF:
0.000353
AC:
2
AN:
5662
European-Non Finnish (NFE)
AF:
0.000180
AC:
190
AN:
1054920
Other (OTH)
AF:
0.00507
AC:
296
AN:
58352
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.479
Heterozygous variant carriers
0
183
366
550
733
916
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
62
124
186
248
310
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00388
AC:
590
AN:
152010
Hom.:
16
Cov.:
32
AF XY:
0.00420
AC XY:
312
AN XY:
74300
show subpopulations
African (AFR)
AF:
0.000434
AC:
18
AN:
41478
American (AMR)
AF:
0.00923
AC:
141
AN:
15270
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3460
East Asian (EAS)
AF:
0.0712
AC:
369
AN:
5180
South Asian (SAS)
AF:
0.00601
AC:
29
AN:
4822
European-Finnish (FIN)
AF:
0.000760
AC:
8
AN:
10530
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.000235
AC:
16
AN:
67960
Other (OTH)
AF:
0.00428
AC:
9
AN:
2104
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.495
Heterozygous variant carriers
0
33
66
98
131
164
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00170
Hom.:
0
Bravo
AF:
0.00479
Asia WGS
AF:
0.0280
AC:
99
AN:
3478

ClinVar

ClinVar submissions as Germline
Significance:Benign/Likely benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
3
not specified (3)
-
-
2
not provided (2)
-
-
1
Noonan syndrome (1)
-
-
1
Noonan syndrome with multiple lentigines (1)
-
-
1
RASopathy (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
PhyloP100
-0.99
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs202103447; hg19: chr3-12650847; COSMIC: COSV52574955; COSMIC: COSV52574955; API